Effectiveness of molnupiravir and nirmatrelvir–ritonavir in hospitalized patients with COVID-19: a target trial emulation study

EYF Wan, VKC Yan, AHY Mok, B Wang… - Annals of internal …, 2023 - acpjournals.org
Background: Whether hospitalized patients benefit from COVID-19 oral antivirals is
uncertain. Objective: To examine the real-world effectiveness of molnupiravir and …
被引用次数：24 相关文章

Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19

EYF Wan, VKC Yan, AHY Mok, ICK Wong… - Annals of Internal …, 2023 - acpjournals.org
Drs. Focosi and Nicastri mentioned a potential conflict between our positive findings and the
negative results from previous RCTs, such as MOVe-IN and EPIC-HOS. We believe that firm …
[HTML] nih.gov

[HTML][HTML] Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19: A Target Trial Emulation Study

EYF Wan, VKC Yan, AHY Mok, B Wang, W Xu… - Annals of Internal … - ncbi.nlm.nih.gov
Background: Whether hospitalized patients benefit from COVID-19 oral antivirals is
uncertain. Objective: To examine the real-world effectiveness of molnupiravir and …

Effectiveness of molnupiravir and nirmatrelvir-ritonavir in hospitalized patients with COVID-19.

EYF Wan, VKC Yan, AHY Mok, B Wang, W Xu… - 2023 - cabidigitallibrary.org
Background: Whether hospitalized patients benefit from COVID-19 oral antivirals is
uncertain. Objective: To examine the real-world effectiveness of molnupiravir and …

Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19: A Target Trial Emulation Study

EYF Wan, VKC Yan, AHY Mok… - Annals of internal …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Whether hospitalized patients benefit from COVID-19 oral antivirals is
uncertain. Objective To examine the real-world effectiveness of molnupiravir and nirmatrelvir …

Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19

EYF Wan, VKC Yan, AHY Mok, BY Wang… - Annals of Internal …, 2023 - hub.hku.hk
Background: Whether hospitalized patients benefit from COVID-19 oral antivirals is
uncertain. Objective: To examine the real-world effectiveness of molnupiravir and …

Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19: A Target Trial Emulation Study.

EYF Wan, VKC Yan, AHY Mok, B Wang… - Annals of Internal …, 2023 - europepmc.org
Whether hospitalized patients benefit from COVID-19 oral antivirals is uncertain. To examine
the real-world effectiveness of molnupiravir and nirmatrelvir-ritonavir in hospitalized patients …

[引用][C] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19.

EYF Wan, VKC Yan, AHY Mok, ICK Wong… - Annals of Internal …, 2023 - europepmc.org
Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19.
- Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19

EYF Wan, VKC Yan, AHY Mok… - Annals of internal …, 2023 - pubmed.ncbi.nlm.nih.gov
Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19
Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19 …